Which region holds the largest market share in the global chronic myelogenous leukemia treatment market ?
North America region holds the largest market share in the global chronic myelogenous leukemia treatment market.
Who are the key players in Chronic Myelogenous Leukemia Treatment Market ?
Major players are Novartis AG, Bristol-Myers Squibb, Teva Pharmaceuticals Industries Ltd., ARIAD Pharmaceuticals, Inc., Pfizer, Inc., Hospira, Inc., CStone Pharma, JD Health, Jiangsu Hengrui Medicine Co Ltd and Shanghai Junshi Biosciences Co., Ltd.